FLT3 and acute myeloid leukemia: The results of this study, as well as those of previously published studies, suggest that class I mutations that affect myeloblast proliferation, such as FLT3, RAS and KIT, are infrequent in AML associated with erythroid predominance [5], [7], [10], [17].